武田制药

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-26-000002  Act: 34  Size: 1 MB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000174  Act: 34  Size: 60 KB 网页链接

$武田制药(TAK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001395064-25-000172  Act: 34  Size: 10 KB 网页链接

$武田制药(TAK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001395064-25-000167  Size: 20 KB 网页链接

$武田制药(TAK)$ 144 Report of proposed sale of securities Accession Number: 0001977746-25-000006  Act: 33  Size: 5 KB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000164  Act: 34  Size: 128 KB 网页链接

$武田制药(TAK)$ 144 Report of proposed sale of securities Accession Number: 0001977608-25-000006  Act: 33  Size: 5 KB 网页链接

$武田制药(TAK)$ 144 Report of proposed sale of securities Accession Number: 0001977620-25-000007  Act: 33  Size: 4 KB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000161  Act: 34  Size: 2 MB 网页链接

$武田制药(TAK)$ 13F-HR Quarterly report filed by institutional managers, Holdings Accession Number: 0001395064-25-000157  Act: 34  Size: 7 KB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000150  Act: 34  Size: 60 KB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000152  Act: 34  Size: 1 MB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000154  Act: 34  Size: 1 MB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000145  Act: 34  Size: 25 KB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000143  Act: 34  Size: 35 KB 网页链接

$武田制药(TAK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001395064-25-000140  Act: 34  Size: 8 KB 网页链接

$武田制药(TAK)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001395064-25-000138  Size: 56 KB 网页链接

$武田制药(TAK)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001395064-25-000130  Act: 34  Size: 15 MB 网页链接

$武田制药(TAK)$ N-PX Annual Report of proxy voting record of management investment companies Accession Number: 0001395064-25-000128  Act: 34  Size: 6 KB 网页链接

$武田制药(TAK)$ 13F-HR Quarterly report filed by institutional managers, Holdings Accession Number: 0001395064-25-000124  Act: 34  Size: 8 KB 网页链接